2012 Ottawa Carcinoid NeuroEndocrine Conference and Symposium
for Medical Professionals, Patients and Caregivers
Friday May 4, 2012 - Sunday May 6, 2012
Location:
Fairmont Chateau Laurier
1 Rideau Street
Ottawa, ON K1N 8S7
(613) 241-1414
The Theme of the Conference is:
- Closing the Gap Between What is and What Can Be for the NET Community.
The Objective of the Conference is:
- Seeking Equitable and Seamless Access to the Full Continuum of Diagnostic and Treatment Option Paths Available, including Quality Patient-Centered Care.
Learning Objectives to be achieved by the end of the Ottawa 2012 CNETS Canada International Conference
Professional health care providers should better be able to:
- discuss in detail the state of the art in 2012 basis for the diagnosis, treatment and management of neuroendocrine tumours;
- explain how NET biomarkers direct further diagnostic, therapeutic and management option paths;
- discuss in detail various therapeutic approaches to NETs;
- promote the patient-centred approach to NET management, and;
- relate and attend to patient and caregiver concerns and needs.
Patients and care givers should better be able to:
- understand the state of the art in 2012 basis for the diagnosis, treatment and management of neuroendocrine tumours;
- understand how NET biomarkers direct further diagnostic, therapeutic and management option paths;
- discuss various therapeutic approaches to NETs with physicians, and;
- be informed and actively participate in the patient-centred approach to manage NETs.
Continuing Medical Education (CME)Credits will be provided by the Canadian Association of Nuclear Medicine (18.5 credits)
Accommodation
There is a lot of information about accommodation for this conference. Please visit the Accommodation page here.
Ottawa Speakers
Please visit our Speakers page to see the full list
Registration 
The cost of registration is $150.00 for patients or caregivers, $200.00 for Allied Medical Professionals, and $250.00 for MDs.
The cost includes all conference materials and all meals from Breakfast on Friday till Breakfast and Mid-Morning snacks on Sunday. Thursday night will have finger foods at the Welcome Reception and will be covered by the conference. There will be no Sunday lunch.
How to Proceed with a One Day Registration for the Ottawa Conference
- Please register the same way as for the full conference by clicking the registration button.
- Please only check the meals on the registration form for the day you are registering.
- When asked on the form how you will pay, please choose "cheque". Complete the registration.
- You now have two options, you can pay by cheque by sending a cheque to CNETS Canada, attention Vernon Holt, Treasurer, 1608 Blakely Drive, Cornwall, ON, K6J 5P4. Please remember to include your conference registration number on the cheque so Vernon can correlate your cheque with your registration. You will receive confirmation of the receipt of your cheque.
- Alternatively, you can pay through PayPal by clicking the PayPal button on this registration page (below). It is imperative that you fill out the registration form regardless, as we need your details for numbers and special mobility and dietary needs.
The cost is:
- $75 is for patients and caregivers
- $100 for nurses
- $125 for physicians
Ottawa Program
Friday May 4 - Sunday May 6, 2012
Ottawa, Ontario, Canada - (All Plenary Sessions will be video-audio recorded with simultaneous translation into French)
Thursday May 3, 2012 Reception (Adam Room)
There will be a reception in the Adam Room. 6.00-9.00. Finger foods. Music by pianist Alison Chung-Yan
Friday May 4, 2012 (Ballroom)
8:00 – 8:20 PLENARY SESSION 1 – Welcome and Introduction
Jim Kormos, Dr. Jean Maroun, Pierrette Breton
8:20-8:45 PLENARY SESSION 2 (Ballroom) – Chair: Dr. Jean Maroun
- An Overview of NETs - Dr. Richard Warner
8:45-8:55 – Q. & A.
8:55-10:00 PLENARY SESSION 3 (Ballroom) – Chair: Dr. Jean Maroun
NET Cancers - Diagnostic Biomarkers:
- Pathology of NETs: Closing the Gap between What Has Been and What Should Be in the Pathology Report – Dr. Sylvia Asa
- Circulating Markers and prognostic indicators for NETs – Prof. Joy Ardill
- The role of imaging as a biomarker for Peptide Receptor Radionuclide Therapy (PRRT) in conjunction with histology – Dr. Eric Liu
8:55-10:00 PARALLEL SESSION 3(a) (Laurier Room) for Patients and Caregivers
- ABCs of NETs for the newly diagnosed - Dr. Edda Gomez-Panzani, Dr. Richard RP Warner
10.00-10.20 BREAK: (French Corridor)
10:20-11:10 PLENARY SESSION 4 (Ballroom) – Chair: Dr. Sylvia Asa
NET Cancers - Diagnostic Tools
- Testing live tumours - what is available? – Dr. Eugene A. Woltering
- Is there a difference in therapies for G2 (intermediate grade) well-differentiated tumours and what difference does Ki-67 or mitotic counts make to therapy decisions? – Dr. Dermot O'Toole
10:20- 11:10 PARALLEL SESSION 4 (a)(Laurier Room) for Patients and Caregivers
- NETs and Nutrition – Leigh-Ann Burns Kamerman
11:10-11:35 Moderated Question and Answer Period (Ballroom)
11:35-12:00 PLENARY SESSION 5 (Ballroom) – Chair: Dr. Eric Liu
- Lung Carcinoids – Past, Present, Future - Dr. Dan Granberg
11:35-12:00 PARALLEL SESSION 5 (a)(Laurier Room) for Patients and Caregivers
- Introduction to biomarkers – what are they and what do they mean for treatment option paths? - Prof. Joy Ardill
12:00-12:10 – Q. & A. (Ballroom)
12:10-1:10 LUNCH:(Adam Room)
1:10-2:00 PLENARY SESSION 6 (Ballroom) - Chair: Dr. Edward M. Wolin
- Panel: Multidisciplinary Tumour Board (Part 1) – two patient case profiles
1:10-2:00 PARALLEL SESSION 6(a) (Laurier Room) for Patients and Caregivers
Introduction to Surgery:
- From in the mouth to out the back…Gastrointestinal NETs…a quick overview including 10 questions to ask your surgeon before your NETs surgery and 10 questions to ask your surgeon after your NETs surgery – Dr. Calvin Law
1:10-2:00 PARALLEL SESSION 6(b) (Burgundy Room) for Patients and Caregivers
- Managing Issues in Living with Lung Carcinoid – Dr. Dan Granberg
2:00-2:50 PLENARY SESSION 7 (Ballroom) - Chair: Dr. Yi-Zarn Wang
Surgery - First line of defense:
- When NETs become liver "mets": current therapeutic strategies – Dr. Calvin Law
- Surgical management of intra-abdominal NETs – Dr. Daryl Gray
2:50-3:10 BREAK: (French Corridor)
3:10-4:00 PLENARY SESSION 8 (Ballroom) - Chair: Dr Janice Pasieka
Surgery: Current and future therapeutics.
- Surgical treatment of Intestinal Neuroendocrine Tumors---What's new? What's next? – Dr. Yi-Zarn Wang
- Multivisceral organ transplantation (MVOT) for metastatic Neuroendocrine Tumors – Dr. Rodrigo Vianna
3:10-4:00 PARALLEL SESSION 8(a) (Laurier Room) for Patients and Caregivers
- Expert Help for Patients in a Local NET Cancer Support Group Setting – Cathy Bouvier
- Mapping of the Interdisciplinary Care Path for Patients with NeuroEndocrine Neoplasms - Rosemary Davidson
4:00- 5:10 PLENARY SESSION 9 (Ballroom) - Chair: Prof. Girish Shah
Research Sessions:
- Mechanisms Underlying NET Development – Dr. Shereen Ezzat
- The Role of Hypoxial Hypercapnia Chemosensing in the Pathophysiology and Malignant Transformation of Carcinoids - Dr. Herman Yeger
- mTOR inhibition and translation control of pancreatic neuroendocrine tumours - Dr. Tommy Alain
- Translational and Clinical research to improve the efficacy of PRRT and the outcomes for NET patients – Dr. Jean-Mathieu Beauregard
4:00-5:10 PARALLEL SESSION 9(a) (Laurier Room) for Patients and Caregivers
Repeat of session 8a:
- Expert Help for Patients in a Local NET Cancer Support Group Setting – Cathy Bouvier
- Mapping of the Interdisciplinary Care Path for Patients with NeuroEndocrine Neoplasms - Rosemary Davidson
5:10-5:30 Moderated Question and Answer Period (Ballroom)
7:30 Dinner (Adam Room) Alexander Masters will speak during dessert at 8:00pm, on "A Journey into the land of the Oncolytic Virus" He is an award winning author, journalist and NET friend, with an abiding interest in Oncolytic Viral Therapy.
Day 2 - SATURDAY May 5, 2012 (Ballroom)
8:00-8:05 Opening Remarks - Jim Kormos
8.05-8:30 PLENARY SESSION 10 (Ballroom) – Chair: Prof. Girish Shah
- Neurocognitive dysfunction – part of the Carcinoid Syndrome or a result of the diagnosis? – Dr. Janice Pasieka
8:30 - 8:55 PLENARY SESSION 11 (Ballroom) - Dr. Al Driedger
- Carcinoid Heart Disease and Management – Dr. Bryan Dias
8:30-8:55 PARALLEL SESSION 11(a) (Laurier Room) for Patients and Caregivers
- M.E.N. syndromes, Paraganglioma, Pheochromocytoma, and other rarer NETs – Dr. Shereen Ezzat
8:55-9:45 PLENARY SESSION 12 (Ballroom) – Chair: Dr. Eric Turcotte
Non-Surgical Treatments – Advanced
- Exciting new developments in systemic therapy of NeuroEndocrine Tumours: somatostatin analogues, biological agents including everolimus and sunitinib, and other systemic therapies - Dr. Edward M. Wolin.
- Locoregional therapy for mNET (RFA/TACE) - Dr. Richard Owen
8:55-9:45 PARALLEL SESSION 12(a) (Laurier Room) for Patients and Caregivers
Management talks - Basic
- Management of post Whipple and post bowel resection GI distress and malabsorption – Cynthia Wheeler
- Nutrition for NET Patients - Leigh Ann Burns Kamerman
- Addressing those significant NET related emotional issues – Prof. Joy Ardill
9:45-10:00 BREAK
10:00-10:50 PLENARY SESSION 13 (Ballroom) – Chair: Dr. Walter Kocha
Non-Surgical Treatments – Advanced (continued)
- Nuclear Medicine treatments for bone metastases - Dr. Robert H. Reid
- Y90 (Theraspheres and SIR Spheres) - 'Selective Internal Radiation Therapy for mNET – Dr. Richard Owen
- NETs: Signaling pathways and chemotherapeutic agents - Dr. Tommy Alain
10:00-10:50 PARALLEL SESSION 13(a) (Laurier Room) for Patients and Caregivers
Management talks – Basic (continued):
- Management of atrophic gastritis in Type I gastric carcinoid – Nurse Practitioner Cynthia Wheeler
- Management of NET symptoms and subsequent issues arising from different treatment paths – Nurse Practitioner Cynthia Wheeler
10:50-12:10 PLENARY SESSION 14 – Chair: Dr. Jean Luc Urbain
Nuclear Medicine – from diagnostic scans to treatments:
- Why do we need Peptide Receptor Radionuclide Therapy (PRRT)? – Dr. Eric Turcotte
- Radioisotope therapies in the treatment of patients with neuroendocrine tumours - Dr. Sandy McEwan
- PRRT in Europe: State-of-the-Art and, now, Quo Vadis? – Dr. Irene Virgolini
12.10-1:10 LUNCH
1:10-2:10 PLENARY SESSION 15 – Chair: Dr. Jean Luc Urbain
Nuclear Medicine – from diagnostic to treatments (continued):
- Are NET surgery and PRRT complementary? – Dr. Eric Liu
- Dosimetry in PRRT: Personalized medicine for NET patients – Dr. Jean-Mathieu Beauregard
- Toxicity of PRRT – Dr. Robert Reid
1:10-2:10 PARALLEL SESSION 15(a) (Laurier Room) for Patients and Caregivers
- What's new in NETs research? Are all of your tumours the same? – Dr. Eugene Woltering
- Overview of Current and Planned Trials for NeuroEndocrine Tumours – Dr Tim Asmis
2:10-3:00 PLENARY SESSION 16 (Ballroom) – Chair: Dr. Eugene Woltering Panel: Multidisciplinary Tumour Board (Part 2) – two patient case profiles
2:10-3:00 PARALLEL SESSION 16(a) (Laurier Room) for Patients and Caregivers
- Diagnostic nuclear medicine for NET patients - Dr. Eric Turcotte
- Therapeutic nuclear medicine for NET patients - Dr. Jean-Mathieu Beauregard
3:00-3.20 BREAK (French Corridor)
3:20-3:55 PLENARY SESSION 17 (Adam Room) - Chair: (TBA)
- Neuroendocrine Neoplasms: Concepts, Recent Changes and Myths – Dr. Walter Kocha
3:55-4:30 PLENARY SESSION 18 (Adam Room) – Chair: Dr. Jean-Mathieu Beauregard
- Neuroendocrine Disease Site Team - Dr. Daryl Gray
4:30-4:50 PLENARY SESSION 19 (Adam Room) - Chair: (TBA)
Clinical Trials: Their Importance and Relevance for Carcinoid-NET patients - Dr. Dr Tim Asmis
4:30-5:15: Moderated Question and Answer Period (Adam Room)
7:00 Dinner (Adam Room)
Alexander Masters will speak during dessert at 8:30pm, on "A Journey into the land of the Oncolytic Virus" He is an award winning author, journalist and NET friend, with an abiding interest in Oncolytic Viral Therapy.
Music by Natalia and Tony and their five-piece jazz blues band.
Day 3 – Sunday May 6, 2012
8:45-10:25 PLENARY SESSION 20 (Adam Room) - Chair: Dr. Sandy McEwan
Panel: Introduction to Centres of Excellence – Challenges Overcome and Challenges Ahead.
Dr. Richard Warner, Dr. Edward Wolin, Dr. Eric Liu, Dr. Eugene Woltering, Dr. Dermot O'Toole, Dr. Daryl Gray, Dr. Calvin Law
10:25-10:40 Break
10:40-11:00: Moderated Question and Answer Period (Adam Room)
11:00-12:15 PLENARY SESSION 21 (Adam Room) – Chair: Jim Kormos
Facilitated small group dialogue and deliberations across all Stakeholder Groups: Conference Participant Responses to Focus Questions to Prioritize Issues and Report Back on Proposed Remedies to Improve NET Patient Care.
12:15-12:25 – Closing Remarks – Jim Kormos
Sponsors
CNETS Canada gratefully acknowledges the following levels of Sponsorship for the Ottawa 2012 International Conference.
Levels of Sponsorship
|
Donation Categories
|
